APDN

Applied DNA Sciences Inc

APDN, USA

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. The company was founded in 1983 and is headquartered in Stony Brook, New York.

https://www.adnas.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
APDN
stock
APDN

Can APDN stock resist market sell offs - Trade Volume Summary & Technical Entry and Exit Alerts DonanımHaber

Read more →
APDN
stock
APDN

Will APDN stock maintain dividend yield - 2025 Stock Rankings & Weekly Chart Analysis and Trade Guides DonanımHaber

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-06-30)

Rating:

HOLD

Target Price:

$1.5

Analyst Picks

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2025-06-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.20

Low 1

High 3

Return on Equity (ROE)

-

Very Low

-54.32 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

-39.71 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-928.79 %

Low 5%

High 15%

Debt to Equity

-

Very High

0.41

Low 1

High 0.3

Investors

* Institutions hold a combined 6.42% of the total shares of Applied DNA Sciences Inc

1.

Anson Funds Management LP

(3.6011%)

since

2025/06/30

2.

Sabby Management LLC

(1.8858%)

since

2025/06/30

3.

UBS Group AG

(0.8997%)

since

2025/06/30

4.

Tower Research Capital LLC

(0.0172%)

since

2025/06/30

5.

SBI Securities Co Ltd

(0.0113%)

since

2025/06/30

6.

BlackRock Inc

(0.0003%)

since

2025/06/30

7.

Advisor Group Holdings, Inc.

(0.0003%)

since

2025/06/30

8.

Bank of America Corp

(0.0003%)

since

2025/06/30

9.

Morgan Stanley - Brokerage Accounts

(0.0002%)

since

2025/06/30

10.

Wells Fargo & Co

(0.0002%)

since

2025/06/30

11.

Mccormack Advisors International

(0.0002%)

since

2025/06/30

12.

Wealth Preservation Advisors

(0.0001%)

since

2025/06/30

13.

Westside Investment Management, Inc.

(0.0001%)

since

2025/06/30

14.

Natixis SA

(0.0001%)

since

2025/06/30

15.

Activest Wealth Management

(0.0001%)

since

2025/06/30

16.

Royal Bank of Canada

(0%)

since

2025/03/31

17.

Goldman Sachs Group Inc

(0%)

since

2025/03/31

18.

Connective Capital Management LLC

(0%)

since

2025/03/31

19.

PFG Investments, LLC

(0%)

since

2025/06/30

20.

Jane Street Group LLC

(0%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

No earnings data available.

Investing Fit Scorecard

(Last Updated 2025-06-30)

Deep Value
Strong Deep Value(6.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1)
Momentum
Moderate Momentum(4.5)
Net Net
Possible Net-Net(3.5)
Quality
Low Quality Business(2.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-06-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-06-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-06-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.